分子モデリング市場の2030年までの予測：製品別、アプローチ別、用途別、エンドユーザー別、地域別の世界分析

Stratistics MRCによると、世界の分子モデリング市場は2023年に58億4,000万米ドルを占め、予測期間中にCAGR 14.5％で成長し、2030年には150億7,000万米ドルに達すると予測されています。

分子モデリングは、医薬品の創製に用いられる手法です。分子の生成や操作、三次元構造、物理化学的特性の記述に役立ちます。分子の挙動や構造の研究に役立ちます。さらに、材料科学や計算生物学にも利用されています。生物学的および分子学的特性を分析するために、さまざまなコンピュータ技術が使用されています。

2022年2月に発表された世界保健機関（WHO）の数字によると、2022年のてんかん患者数は約5,000万人です。調査によると、2022年までに、てんかん患者の約80％が低所得国または中所得国に住むことになります。

薬剤開発と研究

分子モデリングは、創薬や薬剤開発のスピードを上げるために製薬業界やバイオテクノロジー業界が使用する重要なツールです。さらに、この技術の助けを借りて、研究者は潜在的な薬剤候補をスクリーニングし、分子がどのように相互作用するかを予測し、薬剤の特性を向上させることができます。その結果、新薬の市場投入にかかる時間とコストが削減されます。これは、ヘルスケア・サービスの需要が高まり、最先端の治療法が求められていることを考えれば、極めて重要なことです。

計算の複雑さと要求

分子モデリングでは、シミュレーターや複雑な数学的アルゴリズムが頻繁に使用されます。システムが大きく複雑になるにつれて、必要な計算量は指数関数的に増大します。しかし、計算インフラに制約のある小規模な研究グループや組織にとって、高度なモデリング技術を利用することは、利用可能な計算リソースに負担をかけるこの複雑さによって妨げられる可能性があります。

精密医療の利用拡大

患者一人一人の遺伝的・分子的プロファイルに合わせて医療をカスタマイズすることで、精密医療はヘルスケアを完全に変革する可能性を秘めています。さらに、分子モデリングの助けを借りることで、患者固有の薬物反応の特定が容易になり、副作用を最小限に抑え、治療結果を改善することもできます。この方法は患者ケアに大きな影響を与え、神経学や腫瘍学など多くの医療専門分野にまたがります。

生物学的システムの複雑性

複雑なタンパク質間相互作用や細胞プロセスなど、複雑な生物学的システムをモデル化することは非常に困難です。これらのシステムの正確なモデリングと予測は、非線形ダイナミクス、多数の変数、および不確実性のために、極めて困難です。さらに、これらの複雑性に対処するためには、より複雑なモデリング手法の開発と学際的な連携が不可欠です。

COVID-19の影響：

COVID-19の大流行は、分子モデリングの市場にさまざまな影響を与えました。パンデミックは、一方では、ウイルスの構造を迅速に理解し、潜在的な創薬標的を特定し、ワクチン開発を加速する上で、分子モデリングが果たす重要な役割を浮き彫りにしました。さらに、創薬や治療研究における分子モデリングの重要性が高まっています。その一方で、特に学術機関や小規模な研究機関では、サプライチェーンの途絶、遠隔地での作業に関する問題、財政的な制約などにより、一時的に研究開発活動に支障をきたすものもあっています。

予測期間中、サービス分野が最大となる見込み

分子モデリング市場の最大シェアはサービスセグメントに属すると予測されます。分子モデリングのサービスには、コンサルティング、計算解析、ソフトウェアのカスタマイズ、トレーニングなど多くのサービスが含まれます。さらに、この市場の優位性は、分子モデリングを実施し、その結果を読み解く際に、専門的な知識や支援が求められることに起因しています。分子モデリングの複雑さをうまく乗り切るために、多くの組織がサービスプロバイダーの専門知識と経験を利用することを好んでおり、これがサービス分野が最大の市場シェアを占める要因となっています。

予測期間中、創薬分野のCAGRが最も高くなる見込み

分子モデリング市場のCAGRは、創薬分野が最も高いと予測されます。医薬品開発の初期段階において、分子モデリングツールやサービスのニーズが高まっていることが、この成長につながっています。創薬プロセスは、潜在的な薬剤候補の同定、分子構造の改良、相互作用の予測に不可欠な分子モデリングの利用によって加速されます。さらに、製薬業界は新薬を市場に投入する際、革新性と有効性を重視し続けるため、創薬における分子モデリングの需要は、この市場の大きな成長を促進すると予想されます。

最大のシェアを占める地域：

分子モデリング市場は、欧州地域で最大のシェアを占めると予想されます。欧州には多くの製薬企業やバイオテクノロジー企業が立地しており、研究を優先する大学や確立されたヘルスケアシステムもあります。さらに、この地域は共同研究プロジェクトや政府からの資金援助から利益を得ており、様々な産業における分子モデリングアプリケーションの創造性を促しています。医薬品開発、材料科学、環境研究における分子モデリングの採用は、精密医療と持続可能性への取り組みに対する欧州のコミットメントによっても刺激されており、これが市場シェアの拡大に寄与しています。

CAGRが最も高い地域：

分子モデリング市場のCAGRが最も高いのはアジア太平洋地域です。製薬・バイオテクノロジー産業の活況、研究開発の活発化、中国、インド、日本などにおける精密医療の重視の高まりなど、いくつかの要因がこの急成長の原動力となっています。アジア太平洋は、熟練した労働力、技術の進歩、研究実施コストの低さから、分子モデリングサービスやソフトウェアの使用にとって望ましい場所です。さらに、アジア太平洋地域における分子モデリング市場の目覚ましい拡大は、同地域のヘルスケアインフラの成長と、科学研究とイノベーションへの多額の投資によってもたらされています。

無料のカスタマイズサービス

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

• 企業プロファイル
  • 追加市場プレーヤーの包括的プロファイリング（3社まで）
  • 主要企業のSWOT分析（3社まで）
• 地域セグメンテーション
  • 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
• 競合ベンチマーキング
  • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

• 概要
• ステークホルダー
• 調査範囲
• 調査手法
  • データマイニング
  • データ分析
  • データ検証
  • 調査アプローチ
• 調査ソース
  • 1次調査ソース
  • 2次調査ソース
  • 前提条件

第3章 市場動向分析

• 促進要因
• 抑制要因
• 機会
• 脅威
• 製品分析
• アプリケーション分析
• エンドユーザー分析
• 新興市場
• 新型コロナウイルス感染症（COVID-19）の影響

第4章 ポーターのファイブフォース分析

• 供給企業の交渉力
• 買い手の交渉力
• 代替品の脅威
• 新規参入業者の脅威
• 競争企業間の敵対関係

第5章 世界の分子モデリング市場：製品別

• ソフトウェア
• サービス
• その他の製品

第6章 世界の分子モデリング市場：アプローチ別

• 分子力学によるアプローチ
• 量子化学のアプローチ
• 他のアプローチ

第7章 世界の分子モデリング市場：アプリケーション別

• 医薬品開発
• 創薬
• その他の用途

第8章 世界の分子モデリング市場：エンドユーザー別

• 製薬会社およびバイオテクノロジー会社
• 研究センターおよび学術機関
• その他のエンドユーザー

第9章 世界の分子モデリング市場：地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン
  • その他欧州
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • ニュージーランド
  • 韓国
  • その他アジア太平洋地域
• 南米
  • アルゼンチン
  • ブラジル
  • チリ
  • その他南米
• 中東とアフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • カタール
  • 南アフリカ
  • その他中東とアフリカ

第10章 主な発展

• 契約、パートナーシップ、コラボレーション、合弁事業
• 買収と合併
• 新製品の発売
• 事業拡大
• その他の主要戦略

第11章 企業プロファイル

• Thermo Fisher Scientific Inc
• Dassault Systems
• BioSolveIT GmbH
• Schrodinger Llc
• Advanced Chemistry Development, Inc.
• OpenEye Cadence Molecular Sciences
• Centera Lp
• Simulations Plus Inc
• Chemical Computing Group ULC
• Bioinformatics Inc
• Optibrium, Ltd.
• Cresset Acellera Ltd
• Rosa & Co., LLC

List of Tables

• Table 1 Global Molecular Modelling Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global Molecular Modelling Market Outlook, By Product (2021-2030) ($MN)
• Table 3 Global Molecular Modelling Market Outlook, By Software (2021-2030) ($MN)
• Table 4 Global Molecular Modelling Market Outlook, By Services (2021-2030) ($MN)
• Table 5 Global Molecular Modelling Market Outlook, By Other Products (2021-2030) ($MN)
• Table 6 Global Molecular Modelling Market Outlook, By Approach (2021-2030) ($MN)
• Table 7 Global Molecular Modelling Market Outlook, By Molecular Mechanics Approach (2021-2030) ($MN)
• Table 8 Global Molecular Modelling Market Outlook, By Quantum chemistry Approach (2021-2030) ($MN)
• Table 9 Global Molecular Modelling Market Outlook, By Other Approaches (2021-2030) ($MN)
• Table 10 Global Molecular Modelling Market Outlook, By Application (2021-2030) ($MN)
• Table 11 Global Molecular Modelling Market Outlook, By Drug Development (2021-2030) ($MN)
• Table 12 Global Molecular Modelling Market Outlook, By Drug Discovery (2021-2030) ($MN)
• Table 13 Global Molecular Modelling Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 14 Global Molecular Modelling Market Outlook, By End User (2021-2030) ($MN)
• Table 15 Global Molecular Modelling Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
• Table 16 Global Molecular Modelling Market Outlook, By Research Centers and Academic Institutions (2021-2030) ($MN)
• Table 17 Global Molecular Modelling Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 18 North America Molecular Modelling Market Outlook, By Country (2021-2030) ($MN)
• Table 19 North America Molecular Modelling Market Outlook, By Product (2021-2030) ($MN)
• Table 20 North America Molecular Modelling Market Outlook, By Software (2021-2030) ($MN)
• Table 21 North America Molecular Modelling Market Outlook, By Services (2021-2030) ($MN)
• Table 22 North America Molecular Modelling Market Outlook, By Other Products (2021-2030) ($MN)
• Table 23 North America Molecular Modelling Market Outlook, By Approach (2021-2030) ($MN)
• Table 24 North America Molecular Modelling Market Outlook, By Molecular Mechanics Approach (2021-2030) ($MN)
• Table 25 North America Molecular Modelling Market Outlook, By Quantum chemistry Approach (2021-2030) ($MN)
• Table 26 North America Molecular Modelling Market Outlook, By Other Approaches (2021-2030) ($MN)
• Table 27 North America Molecular Modelling Market Outlook, By Application (2021-2030) ($MN)
• Table 28 North America Molecular Modelling Market Outlook, By Drug Development (2021-2030) ($MN)
• Table 29 North America Molecular Modelling Market Outlook, By Drug Discovery (2021-2030) ($MN)
• Table 30 North America Molecular Modelling Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 31 North America Molecular Modelling Market Outlook, By End User (2021-2030) ($MN)
• Table 32 North America Molecular Modelling Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
• Table 33 North America Molecular Modelling Market Outlook, By Research Centers and Academic Institutions (2021-2030) ($MN)
• Table 34 North America Molecular Modelling Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 35 Europe Molecular Modelling Market Outlook, By Country (2021-2030) ($MN)
• Table 36 Europe Molecular Modelling Market Outlook, By Product (2021-2030) ($MN)
• Table 37 Europe Molecular Modelling Market Outlook, By Software (2021-2030) ($MN)
• Table 38 Europe Molecular Modelling Market Outlook, By Services (2021-2030) ($MN)
• Table 39 Europe Molecular Modelling Market Outlook, By Other Products (2021-2030) ($MN)
• Table 40 Europe Molecular Modelling Market Outlook, By Approach (2021-2030) ($MN)
• Table 41 Europe Molecular Modelling Market Outlook, By Molecular Mechanics Approach (2021-2030) ($MN)
• Table 42 Europe Molecular Modelling Market Outlook, By Quantum chemistry Approach (2021-2030) ($MN)
• Table 43 Europe Molecular Modelling Market Outlook, By Other Approaches (2021-2030) ($MN)
• Table 44 Europe Molecular Modelling Market Outlook, By Application (2021-2030) ($MN)
• Table 45 Europe Molecular Modelling Market Outlook, By Drug Development (2021-2030) ($MN)
• Table 46 Europe Molecular Modelling Market Outlook, By Drug Discovery (2021-2030) ($MN)
• Table 47 Europe Molecular Modelling Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 48 Europe Molecular Modelling Market Outlook, By End User (2021-2030) ($MN)
• Table 49 Europe Molecular Modelling Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
• Table 50 Europe Molecular Modelling Market Outlook, By Research Centers and Academic Institutions (2021-2030) ($MN)
• Table 51 Europe Molecular Modelling Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 52 Asia Pacific Molecular Modelling Market Outlook, By Country (2021-2030) ($MN)
• Table 53 Asia Pacific Molecular Modelling Market Outlook, By Product (2021-2030) ($MN)
• Table 54 Asia Pacific Molecular Modelling Market Outlook, By Software (2021-2030) ($MN)
• Table 55 Asia Pacific Molecular Modelling Market Outlook, By Services (2021-2030) ($MN)
• Table 56 Asia Pacific Molecular Modelling Market Outlook, By Other Products (2021-2030) ($MN)
• Table 57 Asia Pacific Molecular Modelling Market Outlook, By Approach (2021-2030) ($MN)
• Table 58 Asia Pacific Molecular Modelling Market Outlook, By Molecular Mechanics Approach (2021-2030) ($MN)
• Table 59 Asia Pacific Molecular Modelling Market Outlook, By Quantum chemistry Approach (2021-2030) ($MN)
• Table 60 Asia Pacific Molecular Modelling Market Outlook, By Other Approaches (2021-2030) ($MN)
• Table 61 Asia Pacific Molecular Modelling Market Outlook, By Application (2021-2030) ($MN)
• Table 62 Asia Pacific Molecular Modelling Market Outlook, By Drug Development (2021-2030) ($MN)
• Table 63 Asia Pacific Molecular Modelling Market Outlook, By Drug Discovery (2021-2030) ($MN)
• Table 64 Asia Pacific Molecular Modelling Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 65 Asia Pacific Molecular Modelling Market Outlook, By End User (2021-2030) ($MN)
• Table 66 Asia Pacific Molecular Modelling Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
• Table 67 Asia Pacific Molecular Modelling Market Outlook, By Research Centers and Academic Institutions (2021-2030) ($MN)
• Table 68 Asia Pacific Molecular Modelling Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 69 South America Molecular Modelling Market Outlook, By Country (2021-2030) ($MN)
• Table 70 South America Molecular Modelling Market Outlook, By Product (2021-2030) ($MN)
• Table 71 South America Molecular Modelling Market Outlook, By Software (2021-2030) ($MN)
• Table 72 South America Molecular Modelling Market Outlook, By Services (2021-2030) ($MN)
• Table 73 South America Molecular Modelling Market Outlook, By Other Products (2021-2030) ($MN)
• Table 74 South America Molecular Modelling Market Outlook, By Approach (2021-2030) ($MN)
• Table 75 South America Molecular Modelling Market Outlook, By Molecular Mechanics Approach (2021-2030) ($MN)
• Table 76 South America Molecular Modelling Market Outlook, By Quantum chemistry Approach (2021-2030) ($MN)
• Table 77 South America Molecular Modelling Market Outlook, By Other Approaches (2021-2030) ($MN)
• Table 78 South America Molecular Modelling Market Outlook, By Application (2021-2030) ($MN)
• Table 79 South America Molecular Modelling Market Outlook, By Drug Development (2021-2030) ($MN)
• Table 80 South America Molecular Modelling Market Outlook, By Drug Discovery (2021-2030) ($MN)
• Table 81 South America Molecular Modelling Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 82 South America Molecular Modelling Market Outlook, By End User (2021-2030) ($MN)
• Table 83 South America Molecular Modelling Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
• Table 84 South America Molecular Modelling Market Outlook, By Research Centers and Academic Institutions (2021-2030) ($MN)
• Table 85 South America Molecular Modelling Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 86 Middle East & Africa Molecular Modelling Market Outlook, By Country (2021-2030) ($MN)
• Table 87 Middle East & Africa Molecular Modelling Market Outlook, By Product (2021-2030) ($MN)
• Table 88 Middle East & Africa Molecular Modelling Market Outlook, By Software (2021-2030) ($MN)
• Table 89 Middle East & Africa Molecular Modelling Market Outlook, By Services (2021-2030) ($MN)
• Table 90 Middle East & Africa Molecular Modelling Market Outlook, By Other Products (2021-2030) ($MN)
• Table 91 Middle East & Africa Molecular Modelling Market Outlook, By Approach (2021-2030) ($MN)
• Table 92 Middle East & Africa Molecular Modelling Market Outlook, By Molecular Mechanics Approach (2021-2030) ($MN)
• Table 93 Middle East & Africa Molecular Modelling Market Outlook, By Quantum chemistry Approach (2021-2030) ($MN)
• Table 94 Middle East & Africa Molecular Modelling Market Outlook, By Other Approaches (2021-2030) ($MN)
• Table 95 Middle East & Africa Molecular Modelling Market Outlook, By Application (2021-2030) ($MN)
• Table 96 Middle East & Africa Molecular Modelling Market Outlook, By Drug Development (2021-2030) ($MN)
• Table 97 Middle East & Africa Molecular Modelling Market Outlook, By Drug Discovery (2021-2030) ($MN)
• Table 98 Middle East & Africa Molecular Modelling Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 99 Middle East & Africa Molecular Modelling Market Outlook, By End User (2021-2030) ($MN)
• Table 100 Middle East & Africa Molecular Modelling Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
• Table 101 Middle East & Africa Molecular Modelling Market Outlook, By Research Centers and Academic Institutions (2021-2030) ($MN)
• Table 102 Middle East & Africa Molecular Modelling Market Outlook, By Other End Users (2021-2030) ($MN)

According to Stratistics MRC, the Global Molecular Modelling Market is accounted for $5.84 billion in 2023 and is expected to reach $15.07 billion by 2030 growing at a CAGR of 14.5% during the forecast period. Molecular modeling is a method used in the creation of pharmaceuticals. It helps in describing the creation or manipulation of molecules, their three-dimensional structures, and their physicochemical characteristics. They aid in the study of molecule behaviour and structure. Additionally, they are used in material science and computational biology. To analyze the biological and molecular properties, various computerized techniques are used.

According to World Health Organsiation figures released in February 2022, there will be around 50 million persons with epilepsy in 2022. According to the research, by 2022, roughly 80% of people with epilepsy will live in countries with low or middle incomes

Market Dynamics:

Driver:

Drug development and research

Molecular modeling is a key tool used by the pharmaceutical and biotechnology industries to speed up drug discovery and development procedures. Moreover, with the aid of this technology, researchers can screen potential drug candidates, predict how molecules will interact, and enhance the properties of drugs. As a result, it takes less time and money to introduce new drugs to the market, which is crucial given the growing demand for healthcare services and the requirement for cutting-edge treatments.

Restraint:

Complexity and demands for computation

Simulators and complex mathematical algorithms are frequently used in molecular modeling. The computational requirements grow exponentially as systems get bigger and more complicated. However, the accessibility of advanced modeling techniques to smaller research groups or organizations with constrained computational infrastructure may be hampered by this complexity, which can strain available computational resources.

Opportunity:

Expanding the use of precision medicine

By customizing medical care to each patient's unique genetic and molecular profile, precision medicine presents the potential to completely transform healthcare. Additionally, the identification of patient-specific drug responses can be made easier with the help of molecular modeling, which also helps to minimize side effects and improve therapeutic results. This method has a significant impact on patient care and crosses many medical specialties, including neurology and oncology.

Threat:

Biological systems complexity

It is extremely difficult to model complex biological systems, such as complex protein-protein interactions or cellular processes. Accurate modeling and prediction of these systems are extremely challenging due to nonlinear dynamics, numerous variables, and uncertainties. Moreover, to deal with these complexities, it is essential to develop more complex modeling methods and multidisciplinary partnerships.

COVID-19 Impact:

The COVID-19 pandemic had a wide range of effects on the market for molecular modeling. The pandemic, on the one hand, highlighted the vital role that molecular modeling plays in quickly understanding the virus's structure, identifying potential drug targets, and speeding up vaccine development. Furthermore, the significance of molecular modeling in drug discovery and therapeutic research was thus increased. On the other hand, some research and development activities were temporarily hampered by supply chain disruptions, issues with remote work, and financial constraints, particularly in academia and smaller research organizations.

The Services segment is expected to be the largest during the forecast period

The molecular modeling market's largest share is anticipated to belong to the services segment. Services for molecular modeling include consulting, computational analysis, software customization, and training, among many other services. Moreover, the dominance of this market is due to the demand for specialized knowledge and assistance when implementing and deciphering the outcomes of molecular modeling. In order to successfully navigate the complexities of molecular modeling, many organizations prefer to use the expertise and experience of service providers, which has led to the services segment holding the largest market share.

The Drug Discovery segment is expected to have the highest CAGR during the forecast period

The molecular modeling market's highest CAGR is anticipated to be held by the drug discovery segment. The increased need for molecular modeling tools and services during the early stages of drug development is credited with this growth. The drug discovery process is sped up by the use of molecular modeling, which is essential for identifying potential drug candidates, improving molecular structures, and forecasting interactions. Additionally, the demand for molecular modeling in drug discovery is anticipated to drive significant growth in this market as the pharmaceutical industry continues to place a high priority on innovation and effectiveness when bringing new medications to market.

Region with largest share:

The molecular modeling market is expected to have the largest share in the European region. A significant number of pharmaceutical and biotechnology firms are located in Europe, along with universities that prioritize research and a well-established healthcare system. Furthermore, the area gains from joint research projects and government funding, which encourages creativity in molecular modeling applications across various industries. The adoption of molecular modeling in drug development, materials science, and environmental research has also been stimulated by Europe's commitment to precision medicine and sustainability initiatives, which has helped to contribute to its sizeable market share.

Region with highest CAGR:

The molecular modeling market has the highest CAGR in the Asia-Pacific region. Several factors, including a booming pharmaceutical and biotechnology industry, increased research and development efforts, and an increasing emphasis on precision medicine in nations like China, India, and Japan, are driving this rapid growth. Asia-Pacific is a desirable location for the use of molecular modeling services and software due to its skilled workforce, technological advancements, and lower cost of conducting research. Moreover, the impressive expansion of the molecular modeling market in Asia-Pacific is being driven by the region's growing healthcare infrastructure and significant investments in scientific research and innovation.

Key players in the market:

Some of the key players in Molecular Modelling market include: Thermo Fisher Scientific Inc, Dassault Systems, BioSolveIT GmbH, Schrodinger Llc , Advanced Chemistry Development, Inc., OpenEye Cadence Molecular Sciences, Centera Lp, Simulations Plus Inc, Chemical Computing Group ULC, Bioinformatics Inc, Optibrium, Ltd., Cresset Acellera Ltd and Rosa & Co., LLC.

Key Developments:

In July 2023, Thermo Fisher Scientific Inc., the world leader in serving science, today announced it has entered into a definitive agreement to acquire CorEvitas, LLC ("CorEvitas"), a leading provider of regulatory-grade, real-world evidence for approved medical treatments and therapies, from Audax Private Equity ("Audax"), for $912.5 million in cash.

In June 2023, Dassault Systems Signs a New Agreement. Tran cosmos has signed a new system integrator alliance (SIA) agreement with Dassault Systems. By expanding the use of Dassault Systems' 3DEXPERIENCE platform and various other industry solutions, and combining them with trans cosmos's expertise in consulting and service delivery, the two companies will contribute to driving value for the end customer.

In January 2023, Schrodinger expands neuroscience work with BMS, Otsuka partnerships. With Bristol Myers Squibb, the company is expanding its previous partnership to include a new discovery program in neurology. Schrodinger previously inked a research deal with the drugmaker in late 2020, with plans to explore pharmaceutical targets in kidney cancer and KRAS-driven tumors, as well as other diseases in neurology and immunology.

Products Covered:

• Software
• Services
• Other Products

Approaches Covered:

• Molecular Mechanics Approach
• Quantum chemistry Approach
• Other Approaches

Applications Covered:

• Drug Development
• Drug Discovery
• Other Applications

End Users Covered:

• Pharmaceutical and Biotechnology Companies
• Research Centers and Academic Institutions
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Application Analysis
• 3.8 End User Analysis
• 3.9 Emerging Markets
• 3.10 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Molecular Modelling Market, By Product

• 5.1 Introduction
• 5.2 Software
• 5.3 Services
• 5.4 Other Products

6 Global Molecular Modelling Market, By Approach

• 6.1 Introduction
• 6.2 Molecular Mechanics Approach
• 6.3 Quantum chemistry Approach
• 6.4 Other Approaches

7 Global Molecular Modelling Market, By Application

• 7.1 Introduction
• 7.2 Drug Development
• 7.3 Drug Discovery
• 7.4 Other Applications

8 Global Molecular Modelling Market, By End User

• 8.1 Introduction
• 8.2 Pharmaceutical and Biotechnology Companies
• 8.3 Research Centers and Academic Institutions
• 8.4 Other End Users

9 Global Molecular Modelling Market, By Geography

• 9.1 Introduction
• 9.2 North America
  • 9.2.1 US
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 Italy
  • 9.3.4 France
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 New Zealand
  • 9.4.6 South Korea
  • 9.4.7 Rest of Asia Pacific
• 9.5 South America
  • 9.5.1 Argentina
  • 9.5.2 Brazil
  • 9.5.3 Chile
  • 9.5.4 Rest of South America
• 9.6 Middle East & Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 UAE
  • 9.6.3 Qatar
  • 9.6.4 South Africa
  • 9.6.5 Rest of Middle East & Africa

10 Key Developments

• 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 10.2 Acquisitions & Mergers
• 10.3 New Product Launch
• 10.4 Expansions
• 10.5 Other Key Strategies

11 Company Profiling

• 11.1 Thermo Fisher Scientific Inc
• 11.2 Dassault Systems
• 11.3 BioSolveIT GmbH
• 11.4 Schrodinger Llc
• 11.5 Advanced Chemistry Development, Inc.
• 11.6 OpenEye Cadence Molecular Sciences
• 11.7 Centera Lp
• 11.8 Simulations Plus Inc
• 11.9 Chemical Computing Group ULC
• 11.10 Bioinformatics Inc
• 11.11 Optibrium, Ltd.
• 11.12 Cresset Acellera Ltd
• 11.13 Rosa & Co., LLC